578 related articles for article (PubMed ID: 29172780)
21. Vaccine adjuvant safety: the elephant in the room.
Petrovsky N
Expert Rev Vaccines; 2013 Jul; 12(7):715-7. PubMed ID: 23885815
[No Abstract] [Full Text] [Related]
22. [Adjuvants as factors improving efficiency of vaccination].
Chodaczek G
Postepy Hig Med Dosw (Online); 2004 Mar; 58():47-59. PubMed ID: 15069382
[TBL] [Abstract][Full Text] [Related]
23. Vaccine adjuvants.
Macy DW
Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):206-11. PubMed ID: 9283246
[TBL] [Abstract][Full Text] [Related]
24. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
[TBL] [Abstract][Full Text] [Related]
25. Modes of Action for Mucosal Vaccine Adjuvants.
Aoshi T
Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
[TBL] [Abstract][Full Text] [Related]
26. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity.
Lawson LB; Norton EB; Clements JD
Curr Opin Immunol; 2011 Jun; 23(3):414-20. PubMed ID: 21511452
[TBL] [Abstract][Full Text] [Related]
27. Molecular signatures of vaccine adjuvants.
Olafsdottir T; Lindqvist M; Harandi AM
Vaccine; 2015 Sep; 33(40):5302-7. PubMed ID: 25989447
[TBL] [Abstract][Full Text] [Related]
28. Vaccine adjuvants: current challenges and future approaches.
Wilson-Welder JH; Torres MP; Kipper MJ; Mallapragada SK; Wannemuehler MJ; Narasimhan B
J Pharm Sci; 2009 Apr; 98(4):1278-316. PubMed ID: 18704954
[TBL] [Abstract][Full Text] [Related]
29. Are we entering a new age for human vaccine adjuvants?
O'Hagan DT; Fox CB
Expert Rev Vaccines; 2015 Jul; 14(7):909-11. PubMed ID: 25947042
[TBL] [Abstract][Full Text] [Related]
30. IABS international scientific workshop--Mode of Action of Adjuvants: implications for vaccine safety and design, April 29-30, 2010, Bethesda, MD, USA.
Seemann S; Dodet B
Vaccine; 2011 Apr; 29(17):3340. PubMed ID: 21335035
[No Abstract] [Full Text] [Related]
31. Adjuvant strategies to improve vaccination of the elderly population.
Weinberger B
Curr Opin Pharmacol; 2018 Aug; 41():34-41. PubMed ID: 29677646
[TBL] [Abstract][Full Text] [Related]
32. GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives.
Garçon N; Chomez P; Van Mechelen M
Expert Rev Vaccines; 2007 Oct; 6(5):723-39. PubMed ID: 17931153
[TBL] [Abstract][Full Text] [Related]
33. Principles in Immunology for the Design and Development of Vaccines.
Meyer CU; Zepp F
Methods Mol Biol; 2022; 2410():27-56. PubMed ID: 34914041
[TBL] [Abstract][Full Text] [Related]
34. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction.
Mills KH
Immunol Lett; 2009 Feb; 122(2):108-11. PubMed ID: 19100777
[TBL] [Abstract][Full Text] [Related]
35. [Novel vaccines. Vaccinations in the near and distant future].
Wack A; Seubert A; Hilleringmann M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Nov; 52(11):1083-90. PubMed ID: 19760246
[TBL] [Abstract][Full Text] [Related]
36. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
de Veer M; Meeusen E
Discov Med; 2011 Sep; 12(64):195-204. PubMed ID: 21955847
[TBL] [Abstract][Full Text] [Related]
37. Delivery strategies to enhance oral vaccination against enteric infections.
Davitt CJ; Lavelle EC
Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
[TBL] [Abstract][Full Text] [Related]
38. Designing the Next Generation of Vaccines: Relevance for Future Pandemics.
Domínguez-Andrés J; van Crevel R; Divangahi M; Netea MG
mBio; 2020 Dec; 11(6):. PubMed ID: 33443120
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine.
Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L
J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122
[TBL] [Abstract][Full Text] [Related]
40. Vaccine adjuvants.
Reed SG
Expert Rev Vaccines; 2013 Jul; 12(7):705-6. PubMed ID: 23885812
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
